Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation

Transplant Immunology

Volumn 16, Issue 2, 2006, Pages 117-124

  Toubai, Tomomi ^a   Tanaka, Junji ^a   Nishihira, Jun ^b   Ohkawara, Tatsuya ^b   Hirate, Daisuke ^a   Kondo, Nobuo ^b   Tone, Somako ^b   Shono, Yusuke ^a   Ibata, Makoto ^a   Sugita, Junichi ^a   Kato, Naoko ^a   Miura, Yoko ^a   Iwao, Noriaki ^a   Ota, Shuichi ^a   Imamura, Masahiro ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b GeneticLab Co Ltd   (Japan)

Author keywords

Acute graft versus host disease; Experimental hematopoietic stem cell transplantation; Macrophage migration inhibitory factor (MIF); MIF knock out (MIF KO) mice

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; DISEASE COURSE; DRUG EFFECT; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; KNOCKOUT MOUSE; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCORING SYSTEM; SPLEEN CELL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; WILD TYPE;

ACUTE DISEASE; ANIMALS; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GRAFT VS HOST DISEASE; HUMANS; LIVER; LYMPHOCYTES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; SPLEEN; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33746215041     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.05.001     Document Type: Article

References (31)

1. Deeg H.J., and Storb R. Graft-versus-host disease: pathophysiological and clinical aspects. Annu Rev Med 35 (1984) 11-24
2. Ferrara J.L., Levy R., and Chao N.J. Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 5 6 (1999) 347-356
3. Hill G.R., and Ferrara J.L. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic Bone Marrow Transplantation. Blood 95 9 (2000) 2754-2759
4. Shlomchik W.D., Couzens M.S., Tang C.B., McNiff J., Robert M.E., Liu J., et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285 5426 (1999) 412-415
5. Bloom B.R., and Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153 731 (1966) 80-82
6. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 56 1 (1966) 72-77
7. Bucala R. MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response. FASEB J 10 14 (1996) 1607-1613
8. Nishihira J. Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J Interferon Cytokine Res 20 9 (2000) 751-762
9. Bernhagen J., Calandra T., Mitchell R.A., Martin S.B., Tracey K.J., Voelter W., et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365 6448 (1993) 756-759
10. Calandra T., Bernhagen J., Mitchell R.A., and Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179 6 (1994) 1895-1902
11. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., et al. An essential regulatory role for macrophage migration inhibitory factor in T cell activation. Proc Natl Acad Sci U S A 93 15 (1996) 7849-7854
12. Onodera S., Tanji H., Suzuki K., Kaneda K., Mizne Y., Sagawa A., et al. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 11 2 (1999) 163-167
13. Donnelly S.C., Haslett C., Reid P.T., Grant I.S., Wallace W.A., Metz C.N., et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3 3 (1997) 320-323
14. Lan H.Y., Yang N., Nikolic-Paterson D.J., Yu X.Q., Mu W., Isbel N.M., et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57 2 (2000) 499-509
15. Matsumoto K., Maruyama N., Maruyama T., Ohnishi Y., Nonaka S., Inoshita A., et al. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis. Clin Exp Immunol 139 2 (2005) 338-347
16. Selvi E., Tripodi S.A., Catenaccio M., Lorenzini S., Chindamo D., Manganelli S., et al. Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis. Ann Rheum Dis 62 5 (2003) 460-464
17. de Jong Y.P., Abadia-Molina A.C., Satoskar A.R., Clarke K., Rietdijk S.T., Faubion W.A., et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2 11 (2001) 1061-1066
18. Ohkawara T., Nishihira J., Takeda H., Hige S., Kato M., Sugiyama T., et al. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 123 1 (2002) 256-270
19. Lan H.Y., Yang N., Brown F.G., Isbel N.M., Nikolic-Paterson D.J., Mu W., et al. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 66 11 (1998) 1465-1471
20. Brown F.G., Nikolic-Paterson D.J., Metz C., Bucala R., Atkins R.C., and Lan H.Y. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat. Clin Exp Immunol 118 2 (1999) 329-336
21. Lo J.W., Leung A.Y., Huang X.R., Lie A.K., Metz C., Bucala R., et al. Macrophage migration inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 30 6 (2002) 375-380
22. Jose M.D., David J.R., Atkins R.C., and Chadban S.J. Blockade of macrophage migration inhibitory factor does not prevent acute renal allograft rejection. Am J Transplant 3 9 (2003) 1099-1106
23. Demir Y., Chen Y., Metz C., Renz H., and Heeger P.S. Cardiac allograft rejection in the absence of macrophage migration inhibitory factor. Transplantation 76 1 (2003) 244-247
24. Honma N., Koseki H., Akasaka T., Nakayama T., Taniguchi M., Serizawa I., et al. Deficiency of the macrophage migration inhibitory factor gene has no significant on endotoxaemia. Immunology 100 1 (2000) 84-90
25. Cooke K.R., Kobzik L., Martin T.R., Brewer J., Delmonte Jr. J., Crawford J.M., et al. An experimental model of idiopathic pneumonia syndrome after Bone Marrow Transplantation: I. The roles of minor H antigens and endotoxin. Blood 88 8 (1996) 3230-3239
26. Abe R., Peng T., Sailors J., Bucala R., and Metz C.N. Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol 166 2 (2001) 747-753
27. Bernhagen J., Bacher M., Calandra T., Metz C.N., Doty S.B., Donnelly T., et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med 183 1 (1996) 277-282
28. Lan H.Y., Bacher M., Yang N., Mu W., Nikolic-Paterson D.J., Metz C., et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 185 8 (1997) 1455-1465
29. Ferrara J.L., Cooke K.R., and Teshima T. The pathophysiology of acute graft-versus-host disease. Int J Hematol 78 3 (2003) 181-187
30. Satoskar A.R., Bozza M., Rodriguez Sosa M., Lin G., and David J.R. Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection. Infect Immun 69 2 (2001) 906-911
31. Bozza M., Satoskar A.R., Lin G., Lu B., Humbles A.A., Gerard C., et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189 2 (1999) 341-346